| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |